StartUp Health July 21, 2021
More than $740M in health innovation funding was reported this week, including rounds for two StartUp Health portfolio companies: Quit Genius and avoMD.
Quit Genius, a London, UK- and New York, NY-based startup on a mission to end addictive behaviors through digital therapeutics, raised a $64M Series B co-led by Kinnevik and Atomico, with participation from Triple Point Ventures, Octopus Ventures and StartUp Health. source>
avoMD, a New York, NY-based startup on a mission to increase the adoption of evidence-based medicine and other critical information at the point of care, raised $3M from Dunamu, Mirae Asset Global Investments, SpringCamp, FuturePlay, and World Trade Ventures. source>
Other recent deals included:
TMRW Life Sciences, a New York, NY-based life sciences technology company...